IE43866B1 - Piperidine derivatives - Google Patents

Piperidine derivatives

Info

Publication number
IE43866B1
IE43866B1 IE2394/76A IE239476A IE43866B1 IE 43866 B1 IE43866 B1 IE 43866B1 IE 2394/76 A IE2394/76 A IE 2394/76A IE 239476 A IE239476 A IE 239476A IE 43866 B1 IE43866 B1 IE 43866B1
Authority
IE
Ireland
Prior art keywords
piperidine
general formula
derivatives
benzoyl
derivative
Prior art date
Application number
IE2394/76A
Other languages
English (en)
Other versions
IE43866L (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IE43866L publication Critical patent/IE43866L/xx
Publication of IE43866B1 publication Critical patent/IE43866B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IE2394/76A 1975-11-07 1976-10-29 Piperidine derivatives IE43866B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IE43866L IE43866L (en) 1977-05-07
IE43866B1 true IE43866B1 (en) 1981-06-17

Family

ID=5961166

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2394/76A IE43866B1 (en) 1975-11-07 1976-10-29 Piperidine derivatives

Country Status (20)

Country Link
US (1) US4243807A (en:Method)
JP (1) JPS6055509B2 (en:Method)
AT (1) AT352726B (en:Method)
BE (1) BE847973A (en:Method)
CA (1) CA1077942A (en:Method)
CH (3) CH624102A5 (en:Method)
DD (1) DD126942A5 (en:Method)
DE (1) DE2549999A1 (en:Method)
DK (1) DK494876A (en:Method)
FI (1) FI763148A7 (en:Method)
FR (1) FR2330678A1 (en:Method)
GB (1) GB1502050A (en:Method)
HU (1) HU171237B (en:Method)
IE (1) IE43866B1 (en:Method)
IT (1) IT1063618B (en:Method)
LU (1) LU76141A1 (en:Method)
NL (1) NL7612286A (en:Method)
SE (1) SE7612234L (en:Method)
SU (3) SU633473A3 (en:Method)
ZA (1) ZA766381B (en:Method)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FI934894L (fi) * 1991-05-07 1993-11-05 Merck & Co Inc Fibrinogenreceptorantagonister
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2144763A1 (en) * 1992-10-14 1994-04-28 George D. Hartman Fibrinogen receptor antagonists
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
KR100403246B1 (ko) * 1995-09-28 2004-02-11 가켄 세이야쿠 가부시키가이샤 ４-메틸렌피페리딘의제조방법
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
JP5405571B2 (ja) * 2008-07-24 2014-02-05 セラヴァンス， インコーポレーテッド ３−（フェノキシフェニルメチル）ピロリジン化合物
TWI461407B (zh) 2008-11-14 2014-11-21 Theravance Biopharma R & D Ip Llc 製備４－〔２－（２－氟苯氧基甲基）苯基〕哌啶化合物之方法
EP2419405A1 (en) * 2009-04-15 2012-02-22 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
EP2454234B1 (en) * 2009-07-13 2018-04-11 Theravance Biopharma R&D IP, LLC 3-phenoxymethylpyrrolidine compounds
WO2011011231A1 (en) 2009-07-21 2011-01-27 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
US8778949B2 (en) * 2010-01-11 2014-07-15 Theravance Biopharma R&D Ip, Llc 1-(2-phenoxymethylphenyl)piperazine compounds
EP2550252B1 (en) * 2010-03-22 2015-05-06 Theravance Biopharma R&D IP, LLC 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
CA2811641A1 (en) 2010-10-11 2012-04-19 Theravance, Inc. Serotonin reuptake inhibitors
WO2012075239A1 (en) 2010-12-03 2012-06-07 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NL7612286A (nl) 1977-05-10
SU633473A3 (ru) 1978-11-15
IE43866L (en) 1977-05-07
DD126942A5 (en:Method) 1977-08-24
HU171237B (hu) 1977-12-28
GB1502050A (en) 1978-02-22
FI763148A7 (en:Method) 1977-05-08
JPS6055509B2 (ja) 1985-12-05
CH627166A5 (en:Method) 1981-12-31
DE2549999A1 (de) 1977-05-12
ATA823776A (de) 1979-03-15
CH625788A5 (en:Method) 1981-10-15
BE847973A (fr) 1977-05-04
CH624102A5 (en:Method) 1981-07-15
DE2549999C2 (en:Method) 1989-01-26
US4243807A (en) 1981-01-06
SU867298A3 (ru) 1981-09-23
SU662009A3 (ru) 1979-05-05
DK494876A (da) 1977-05-08
FR2330678B1 (en:Method) 1980-11-07
AT352726B (de) 1979-10-10
JPS5259163A (en) 1977-05-16
LU76141A1 (en:Method) 1977-05-18
SE7612234L (sv) 1977-05-07
IT1063618B (it) 1985-02-11
ZA766381B (en) 1977-10-26
CA1077942A (en) 1980-05-20
FR2330678A1 (fr) 1977-06-03

Similar Documents

Publication Publication Date Title
IE43866B1 (en) Piperidine derivatives
US5606064A (en) Process for the preparation of benzyl-piperidylmethyl-indanones
EP0223334B1 (en) Process for the preparation of aryl-piperidine carbinols
EP0300617B1 (en) Process for preparing aryl-piperidine carbinols
EP0219934B1 (en) Process for the preparation of aryl-piperidine esters
DK164857B (da) Fremgangsmaade til fremstilling af 2,5-bis(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid
HU226561B1 (en) Process for preparation 4-diphenylmethyl piperidine derivatives and the novel intermediates thereof
DK154079B (da) Fremgangsmaade til fremstilling af 4-halogen-2h-pyran-3(6h)-on-forbindelser
US5112978A (en) Process for preparing alpha (alkyl phenyl)-4(hydroxy-diphenylmethyl)-1-piperidinyl butanol
JP3647455B2 (ja) ３−イソオキサゾールカルボン酸の製造方法
NO312027B1 (no) Fremgangsmåte for fremstilling av O-(3-amino-2- hydroksypropyl)-hydroksiminsyrehalogenider
JP3002043B2 (ja) キノリニウム塩およびその製造方法
US2882318A (en) Hydroxy-methylindanone oximes and method
JP2804559B2 (ja) ２―クロロ―５―クロロメチルピリジンの製造方法
NO742160L (en:Method)
EP1400511B1 (en) Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor
SU189421A1 (ru) СПОСОБ ПОЛУЧЕНИЯ 1-АЦИЛ-4-АРИЛ (АЛКИЛ) СЕМИКАРБАЗИДОВбйБЛ^йТГиЛ
JP2986003B2 (ja) ２−アルキル−３−スチリルオキシランカルボン酸エステル及びその製法
NO750877L (en:Method)
US2873293A (en) Bis(alpha-chloro-isobutyrates) of dihydroxy-benzenes
EP0236754A1 (en) Novel process for preparing 4-acetyl isoquinolinone compounds
KR860000591B1 (ko) 피리딘 카복실산 유도체의 제조방법
SU342347A1 (ru) Способ получения производных имидазолидинона
JP2619189B2 (ja) フタルイミド化合物およびその製造方法
JPH0249311B2 (en:Method)